Consolidation treatment for high risk solid tumors in children with myeloablative chemotherapy and autologous hematopoietic progenitor stem cell transplantation

Autor: Liliana Velasco Hidalgo, Martin Perez Garcia, Mariana Campos Gutiérrez, Rocío Cárdenas Cardós, Alberto Olaya Vargas, Doris Lord Méndez Jácome, Roberto Rivera Luna

Publikováno v: Revista Brasileira de Hematologia e Hemoterapia v.35 n.5 2013
Revista brasileira de hematologia e hemoterapia
Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular (ABHHTC)
instacron:ABHHTC
Revista Brasileira de Hematologia e Hemoterapia
Revista Brasileira de Hematologia e Hemoterapia, Volume: 35, Issue: 5, Pages: 343-346, Published: 2013
Revista Brasileira de Hematologia e Hemoterapia, Vol 35, Iss 5, Pp 343-346 (2013)

BACKGROUND In childhood cancer, consolidation treatment with chemotherapy followed by autologous hematopoietic progenitor stem cell transplantation is currently an accepted treatment modality in patients with high-risk solid tumors or in patients who

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91e29183c3096ada4e5adb38c5435417
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842013000500343